Your browser doesn't support javascript.
loading
Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors.
Nafee, Tarek; Aslam, Aysha; Chi, Gerald; Pahlavani, Seyedmahdi; Nimri, Dima; Kuchkuntla, Aravind Reddy; Talib, Usama; Michalak, Nathan; Daaboul, Yazan; Korjian, Serge; Gallo, Anthony; Gibson, C Michael.
Afiliación
  • Nafee T; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Aslam A; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Chi G; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Pahlavani S; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Nimri D; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Kuchkuntla AR; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Talib U; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Michalak N; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Daaboul Y; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Korjian S; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Gallo A; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
  • Gibson CM; a PERFUSE Study Group, Cardiovascular Division, Department of Medicine , Beth Israel Deaconess Medical Center, Harvard Medical School , Boston , MA , USA.
Expert Rev Cardiovasc Ther ; 15(4): 237-245, 2017 Apr.
Article en En | MEDLINE | ID: mdl-28282497
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Factor Xa / Inhibidores del Factor Xa / Antídotos Límite: Humans Idioma: En Revista: Expert Rev Cardiovasc Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Factor Xa / Inhibidores del Factor Xa / Antídotos Límite: Humans Idioma: En Revista: Expert Rev Cardiovasc Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido